Why the Universal Biosensors (ASX:UBI) share price is up 5% today

The Universal Biosensors, Inc. (ASX: UBI) share price has lifted today. This comes after the company announced that it has signed a new deal with LifeScan.

| More on:
hand on touch screen lit up by a share price chart moving higher

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Universal Biosensors, Inc. (ASX: UBI) share price is on the rise today after the company announced that it has signed a new deal with LifeScan.

During mid-morning trade, shares in the medical diagnostics company reached an intraday high of 46 cents. However, the Universal share price has since retreated to 41 cents, up 5.1%.

Quick take on Universal

Universal is a specialist medical diagnostics company that focuses on the research, development, manufacture and commercialisation of diagnostic devices. Used by both consumers and professionals, these test systems can be adopted in an array of point-of-care (POC) settings.

According to Universal, the POC diagnostic market is worth US$15 billion a year.

What's driving the Universal share price higher?

According to its release, Universal advised that it entered in an exclusive licencing agreement with LifeScan Global Corporation. The agreement will see both parties work together to develop a device that is able to detect and monitor diabetes in animals.

Using LifeScan's technology, Universal aims to manufacture and sell a discrete single point measurement to monitor glucose. The device will include a biosensor, test strip and a meter for diabetes management.

Under the terms, standard customary conditions apply to both Universal and LifeScan. However, once the product is launched, if annual sales drop below US$10 million, the term of the contract will end.

Previously, LifeScan worked with Universal in commercialising and developing a diabetes strip and meter. To date, the company has sold more than 10 billion diabetes strips worldwide.

CEO commentary

Universal CEO Mr John Sharman spoke of the partnership, saying:

LifeScan paid UBI A$44.6 million in 2019 to buy out UBI's royalty stream which was based on the diabetes products developed using UBI technology. Our new deal with LifeScan means that we can use our existing know-how and combine it with the LifeScan technology to develop a new diabetes product for animals, which we will own.

Most if not all of the technology, know-how and manufacturing capability for diabetes strips and meters already exists at UBI and we expect to have a product available for sale within 18 – 24 months. Our ambition is to win a significant share of the animal diabetes market.

Should you invest $1,000 in Universal Biosensors, Inc. right now?

Before you buy Universal Biosensors, Inc. shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Universal Biosensors, Inc. wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Excited couple celebrating success while looking at smartphone.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in May

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Opinions

Investing in high-yield ASX stocks has two major negatives

High-yield stocks do have downsides.

Read more »

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy finish to the week for ASX shares this Friday.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A mature age woman with a groovy short haircut and glasses, sits at her computer, pen in hand thinking about information she is seeing on the screen.
Share Market News

ASX shares in April: 8 key takeaways according to Macquarie

Here are eight key takeaways from April, according to a new note from the broker.

Read more »

Woman looking at a phone with stock market bars in the background.
Share Market News

Market outlook: Should I 'sell in May and go away'?

May is the time to sell... If you believe in fairytales.

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

5 ASX All Ords stocks rocketing higher this week

Investors sent these five ASX All Ords stocks soaring this week. But why?

Read more »